His thesis work focused on developing novel
small molecule inhibitors against protein targets such as survivin and STAT3 that are essential for progression and survival of cancer.
Hu and his collaborator Juan R. Del Valle at the University of South Florida are developing novel
small molecule inhibitors against IRE - 1 to combat cancers associated with high numbers of MDSCs.
Not exact matches
UNC569, a novel
small molecule Mer
inhibitor with efficacy
against acute lymphoblastic leukemia in vitro and in vivo.